Indoco Remedies Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

339.95

+5.10 (+1.52%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

339.95

+5.10 (+1.52%)
16:02 Dec 20

Quality

39/100
Medium Financial Strength

Valuation

36/100
Mid Valuation

Technical

55/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	1241.53	1540.75	1668.61	1817.29	1773.21
Operating Expenses +	1017.26	1213.41	1382.51	1572.97	1573.42
Raw Material	366.24	483.09	514.74	600.67	584.77
Increase Decrease in Cost	-12.13	-26.3	6.55	-41.48	-23.28
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	274.02	293.7	322.58	361.93	368.41
Miscellaneous Expenses	515.21	641.78	744.08	883.17	643.52
Operating Profit	224.27	327.34	286.1	244.32	199.79
Other Income	3.12	2.33	2.34	9.85	7.6
Depreciation	73.13	78.96	70.61	91.87	106.92
Interest	22.26	14.14	25.03	38.02	54.26
Profit before tax and exceptio..	132	236.57	192.79	124.27	46.21
Exceptional Items	0	0	0	11.53	11.53
PBT	132	236.57	192.79	135.8	34.68
Provision for Taxation	38.95	81.77	50.54	38.79	28.34
Net Profit	93.05	154.8	142.25	97	29.4
NET Profit after MI	93.05	154.8	142.25	98.46	32.06
EPS	10.1	16.8	15.44	10.53	3.19
Operating Profit Margin (%)	18.06	21.25	17.15	13.44	11.27
Net Profit Margin (%)	7.49	10.05	8.53	5.42	1.81

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	58.80	58.80	58.70	58.70	58.70
FII	1.70	1.50	1.90	1.70	1.60
MF	16.70	17.00	17.90	18.20	16.60
Public	21.30	21.10	19.90	20.00	21.90
Others	0.00	0.00	0.10	0.10	0.00
Others	1.50	1.60	1.50	1.30	1.20